Literature DB >> 24077899

Noninvasive evaluation of cardiac autonomic modulation in children with primary Raynaud’s phenomenon: a controlled study.

Mehmet Burhan Oflaz, İbrahim Ece, Ayşe Esin Kibar, Şevket Ballı, Demet Alaygut, Ahmet Sami Guven, Fatih Bolat, Fatma Duksal, Ömer Cevit.   

Abstract

This study aimed to objectively evaluate autonomic nervous function in children with primary Raynaud’s phenomenon (PRP). Thirty-two children with PRP and 30 healthy subjects were included in the study. We analyzed heart rate variability (HRV) in the time domain by the following six standard time-domain measures: standard deviation of all normal R-R intervals during 24 h (SDNN), standard deviation of all normal R-R intervals for all 5-min segments (SDNNi), standard deviation of the average normal R-R intervals for all 5-min segments (SDANN), root mean square of the successive normal R-R interval difference, percentage of successive normal R-R intervals longer than 50 ms, and triangular index (integral of the density distribution of NN intervals divided by the maximum of the density distribution). The mean heart rate throughout 24 h was significantly higher in the PRP group than in the control group (p = 0.001). Although heart rate during the activity period was not significantly different from that during the night period, it was higher in the PRP group than in the control group (p = 0.002). In children with PRP, HRV analysis showed significantly lower values of SDNN (p = 0.01), SDNNi (p = 0.005), SDANN (p = 0.02), and HRV triangular index (p = 0.02) compared with the control group. HRV analysis for sympathovagal balance demonstrated a preponderance for the sympathetic component in patients with PRP. We conclude that all time-domain parameters evaluated in HRV analysis are significantly lower in children with PRP than in healthy subjects.

Entities:  

Mesh:

Year:  2014        PMID: 24077899     DOI: 10.1007/s10067-013-2393-1

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  19 in total

1.  Correlations between indices of heart rate variability in healthy children and children with congenital heart disease.

Authors:  M M Massin; B Derkenne; G von Bernuth
Journal:  Cardiology       Date:  1999       Impact factor: 1.869

Review 2.  Raynaud's phenomenon: epidemiology and risk factors.

Authors:  Liana Fraenkel
Journal:  Curr Rheumatol Rep       Date:  2002-04       Impact factor: 4.592

Review 3.  Pathogenesis of Raynaud's phenomenon.

Authors:  A L Herrick
Journal:  Rheumatology (Oxford)       Date:  2005-03-01       Impact factor: 7.580

4.  Twenty-four hour heart period variability in systemic sclerosis.

Authors:  S Morelli; G Piccirillo; F Fimognari; A Sgreccia; L Ferrante; G Morabito; P De Marzio; G Valesini; V Marigliano
Journal:  J Rheumatol       Date:  1996-04       Impact factor: 4.666

5.  Raynaud's phenomenon in children: a retrospective review of 123 patients.

Authors:  Peter A Nigrovic; Robert C Fuhlbrigge; Robert P Sundel
Journal:  Pediatrics       Date:  2003-04       Impact factor: 7.124

6.  Exaggerated postural vasoconstrictor reflex in Raynaud's phenomenon.

Authors:  N Olsen; O U Petring; N Rossing
Journal:  Br Med J (Clin Res Ed)       Date:  1987-05-09

7.  Autonomic dysfunction and microvascular damage in systemic sclerosis.

Authors:  Manuela Di Franco; Michele Paradiso; Valeria Riccieri; Stefania Basili; Antonio Mammarella; Guido Valesini
Journal:  Clin Rheumatol       Date:  2007-01-18       Impact factor: 2.980

Review 8.  Raynaud's phenomenon as an early sign of connective tissue diseases.

Authors:  C G Kallenberg
Journal:  Vasa Suppl       Date:  1992

9.  Autonomic nervous system dysfunction in sclerodermic and primary Raynaud's phenomenon.

Authors:  P Pancera; S Sansone; B Presciuttini; L Montagna; S Cerù; C Lunardi; A Lechi
Journal:  Clin Sci (Lond)       Date:  1999-01       Impact factor: 6.124

Review 10.  Raynaud's phenomenon: a proposal for classification.

Authors:  E C LeRoy; T A Medsger
Journal:  Clin Exp Rheumatol       Date:  1992 Sep-Oct       Impact factor: 4.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.